Positron Emission Tomography Imaging in Sarcoidosis

Overview

Journal World J Nucl Med

Publisher Thieme

Specialty Nuclear Medicine

Date 2014 Aug 29

PMID 25165420

Citations 3

Authors

Beth Vettiyil

Nikitha Gupta

Rajesh Kumar

Affiliations

Soon will be listed here.

Abstract

Sarcoidosis is a chronic granulomatous disease of unknown origin. There are several modalities for diagnosis, staging and therapeutic management of patients with sarcoidosis. Among these, whole-body F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography is found to useful in patients with complex and multisystem forms of sarcoidosis. Other modalities include Gallium scanning, assesment of angiotensin converting enzyme levels in blood, chest radiography, mediastinoscopy etcetera.

Citing Articles

Neurosarcoidosis, Coccidioidomycosis, or Both!.

Akhavanrezayat A, Matsumiya W, Ongpalakorn P, Ghoraba H, Or C, Khojasteh Jafari H Int Med Case Rep J. 2024; 16:887-895.

PMID: 38164515 PMC: 10758176. DOI: 10.2147/IMCRJ.S434632.

Macrovasculature and positron emission tomography (PET) standardized uptake value in patients with lung cancer.

Pu J, Leader J, Zhang D, Beeche C, Sechrist J, Pennathur A Med Phys. 2021; 48(10):6237-6246.

PMID: 34382221 PMC: 8590108. DOI: 10.1002/mp.15158.

Atypical Optic Neuritis.

Gaier E, Boudreault K, Rizzo 3rd J, Falardeau J, Cestari D Curr Neurol Neurosci Rep. 2015; 15(12):76.

PMID: 26467052 DOI: 10.1007/s11910-015-0598-1.

References

Avram A, Mackie G, Schneider B, Kalemkerian G, Shulkin B . Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide. Clin Nucl Med. 2006; 31(4):197-200. DOI: 10.1097/01.rlu.0000204200.66112.a9. View

Sulica R, Teirstein A, Kakarla S, Nemani N, Behnegar A, Padilla M . Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest. 2005; 128(3):1483-9. DOI: 10.1378/chest.128.3.1483. View

Teirstein A, Machac J, Almeida O, Lu P, Padilla M, Iannuzzi M . Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest. 2007; 132(6):1949-53. DOI: 10.1378/chest.07-1178. View

Gal A, Koss M . The pathology of sarcoidosis. Curr Opin Pulm Med. 2002; 8(5):445-51. DOI: 10.1097/00063198-200209000-00018. View

Kaira K, Ishizuka T, Yanagitani N, Sunaga N, Hisada T, Mori M . Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis. Clin Nucl Med. 2007; 32(2):114-6. DOI: 10.1097/01.rlu.0000252216.68848.d7. View

Lewis P, Salama A . Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med. 1994; 35(10):1647-9. View

Schaefer-Prokop C, Prokop M, Fleischmann D, Herold C . High-resolution CT of diffuse interstitial lung disease: key findings in common disorders. Eur Radiol. 2001; 11(3):373-92. DOI: 10.1007/s003300000648. View

MIKHAIL J, Shepherd M, MITCHELL D . Mediastinal lymph node biopsy in sarcoidosis. Endoscopy. 1979; 11(1):5-8. DOI: 10.1055/s-0028-1098315. View

Pietinalho A, Ohmichi M, Lofroos A, Hiraga Y, Selroos O . The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis. 2000; 17(2):158-66. View

10.

Iannuzzi M, Maliarik M, Rybicki B . Nomination of a candidate susceptibility gene in sarcoidosis: the complement receptor 1 gene. Am J Respir Cell Mol Biol. 2002; 27(1):3-7. DOI: 10.1165/ajrcmb.27.1.f243. View

11.

Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E . Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2007; 35(5):933-41. DOI: 10.1007/s00259-007-0650-8. View

12.

Smojver-Jezek S, Peros-Golubicic T, Tekavec-Trkanjec J, Mazuranic I, Alilovic M . Transbronchial fine needle aspiration cytology in the diagnosis of mediastinal/hilar sarcoidosis. Cytopathology. 2007; 18(1):3-7. DOI: 10.1111/j.1365-2303.2006.00336.x. View

13.

Scadding J . Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J. 1961; 2(5261):1165-72. PMC: 1970202. DOI: 10.1136/bmj.2.5261.1165. View

14.

Judson M, Baughman R, Teirstein A, Terrin M, Yeager Jr H . Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999; 16(1):75-86. View

15.

Futamatsu H, Suzuki J, Adachi S, Okada H, Otomo K, Ohara T . Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia. Int J Cardiovasc Imaging. 2006; 22(3-4):443-8. DOI: 10.1007/s10554-005-9043-x. View

16.

Zhuang H, Duarte P, Pourdehand M, Shnier D, Alavi A . Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med. 2000; 25(4):281-4. DOI: 10.1097/00003072-200004000-00009. View

17.

Mihailovic Vucinic V . What is the future of methotrexate in sarcoidosis? A study and review. Curr Opin Pulm Med. 2002; 8(5):470-6. DOI: 10.1097/00063198-200209000-00022. View

18.

Chittock D, Joseph M, Paterson N, McFadden R . Necrotizing sarcoid granulomatosis with pleural involvement. Clinical and radiographic features. Chest. 1994; 106(3):672-6. DOI: 10.1378/chest.106.3.672. View

19.

Smedema J, White L, Klopper A . FDG-PET and MIBI-Tc SPECT as follow-up tools in a patient with cardiac sarcoidosis requiring a pacemaker. Cardiovasc J Afr. 2008; 19(6):309-10. View

20.

Joseph F, Scolding N . Sarcoidosis of the nervous system. Pract Neurol. 2007; 7(4):234-44. DOI: 10.1136/jnnp.2007.124263. View